Sommaire

Numéro précédent | Numéro suivant

• • ·Gefitinib: phoenix from the flames

    Page :737

     
• • ·Refining systemic therapy for early breast cancer: difficulties with subtraction

    Page :738-739

    David Dodwell, Helen Thorpe, Robert Coleman

     
• • ·Sunitinib in renal-cell carcinoma: expanded indications

    Page :740

    Toni K Choueiri, Joaquim Bellmunt

     
• • ·Diagnosing patients with hereditary paraganglial tumours

    Page :741

    Zoran Erlic, Hartmut PH Neumann

     
• • ·Multimodal treatment with surgical resection for stage IIIB non-small-cell lung cancer

    Page :742-743

    Arjun Pennathur, James D Luketich

     
• • ·Sunitinib and the benefits of a negative study

    Page :743-744

    Alejandro Forner, Josep M Llovet, Jordi Bruix

     
• • ·Cost-effectiveness of medical imaging

    Page :744-745

    Michael M Graham

     
• • ·Managing the unmanageable

    Page :745-746

    Robert W Atcher

     
• • ·Circumcision to prevent HPV infection

    Page :746-747

    Robert S Van Howe, Michelle R Storms

    
• • ·Palliative sedation is not controversial

    Page :747-748

    Jeroen Hasselaar, Stans Verhagen, Rob Reuzel, Evert van Leeuwen, Kris Vissers

    
• • ·Erratum

    Page :748

    
• • ·Is paperwork suffocating British clinical research?

    Page :749-750

    Adrian Burton

     
• • ·A review of human carcinogens—Part D: radiation

    Page :751-752

    Fatiha El Ghissassi, Robert Baan, Kurt Straif, Yann Grosse, Béatrice Secretan, Véronique Bouvard, Lamia Benbrahim-Tallaa, Neela Guha, Crystal Freeman, Laurent Galichet, Vincent Cogliano, on behalf of the WHO International Agency for Research on Cancer Monograph Working Group

     
• • ·2009 International Symposium on Supportive Care in Cancer

    Page :753

    Emma Grainger

    Plan Plan
• • ·World congress of the International Academy of Oral Oncology

    Page :754

    Audrey Ceschia

    Plan Plan
• • ·Oncology Information Exchange opens up databases

    Page :755

    Richard Begent

     
• • ·My Sister’s Keeper

    Page :756

    Jill Jouret

     
• • ·Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial

    Page :757-763

    Martin E Gore, Cezary Szczylik, Camillo Porta, Sergio Bracarda, Georg A Bjarnason, Stéphane Oudard, Subramanian Hariharan, Se-Hoon Lee, John Haanen, Daniel Castellano, Eduard Vrdoljak, Patrick Schöffski, Paul Mainwaring, Alejandra Nieto, Jinyu Yuan, Ronald Bukowski

    Résumé Résumé Plan Plan  
• • ·An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis

    Page :764-771

    Francien H van Nederveen, José Gaal, Judith Favier, Esther Korpershoek, Rogier A Oldenburg, Elly MCA de Bruyn, Hein FBM Sleddens, Pieter Derkx, Julie Rivière, Hilde Dannenberg, Bart-Jeroen Petri, Paul Komminoth, Karel Pacak, Wim CJ Hop, Patrick J Pollard, Massimo Mannelli, Jean-Pierre Bayley, Aurel Perren, Stephan Niemann, Albert A Verhofstad, Adriaan P de Bruïne, Eamonn R Maher, Frédérique Tissier, Tchao Méatchi, Cécile Badoual, Jérôme Bertherat, Laurence Amar, Despoina Alataki, Eric Van Marck, Francesco Ferrau, Jerney François, Wouter W de Herder, Mark-Paul FM Vrancken Peeters, Anne van Linge, Jacques WM Lenders, Anne-Paule Gimenez-Roqueplo, Ronald R de Krijger, Winand NM Dinjens

    Résumé Résumé Plan Plan   
• • ·TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies

    Page :772-784

    Stefanie J Klug, Meike Ressing, Jochem Koenig, Martin C Abba, Theodoros Agorastos, Sylvia MF Brenna, Marco Ciotti, BR Das, Annarosa Del Mistro, Aleksandra Dybikowska, Anna R Giuliano, Zivile Gudleviciene, Ulf Gyllensten, Andrea LF Haws, Aslaug Helland, C Simon Herrington, Alan Hildesheim, Olivier Humbey, Sun H Jee, Jae Weon Kim, Margaret M Madeleine, Joseph Menczer, Hextan YS Ngan, Akira Nishikawa, Yoshimitsu Niwa, Rosemary Pegoraro, MR Pillai, Gulielmina Ranzani, Giovanni Rezza, Adam N Rosenthal, Susanta Roychoudhury, Dhananjaya Saranath, Virginia M Schmitt, Sharmila Sengupta, Wannapa Settheetham-Ishida, Hiroshi Shirasawa, Peter JF Snijders, Mark H Stoler, Angel E Suárez-Rincón, Krisztina Szarka, Ruth Tachezy, Masatsugu Ueda, Ate GJ van der Zee, Magnus von Knebel Doeberitz, Ming-Tsang Wu, Tsuyoshi Yamashita, Ingeborg Zehbe, Maria Blettner

    Résumé Résumé Plan Plan   
• • ·Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial

    Page :785-793

    Roger Stupp, Michael Mayer, Roger Kann, Walter Weder, Abderahim Zouhair, Daniel C Betticher, Arnaud D Roth, Rolf A Stahel, Sabine Balmer Majno, Solange Peters, Lorenz Jost, Markus Furrer, Sandra Thierstein, Ralph A Schmid, Shu-Fang Hsu-Schmitz, René-Olivier Mirimanoff, Hans-Beat Ris, Miklos Pless

    Résumé Résumé Plan Plan   
• • ·Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II study

    Page :794-800

    Sandrine Faivre, Eric Raymond, Eveline Boucher, Jean Douillard, Ho Y Lim, Jun S Kim, Magaly Zappa, Silvana Lanzalone, Xun Lin, Samuel DePrimo, Charles Harmon, Ana Ruiz-Garcia, Maria J Lechuga, Ann Lii Cheng

    Résumé Résumé Plan Plan  
• • ·Liver resection for metastatic colorectal cancer in the presence of extrahepatic disease

    Page :801-809

    Darren R Carpizo, Michael D’Angelica

    Résumé Résumé Plan Plan  
• • ·Reconstruction after wide excision of primary cutaneous melanomas: part II—the extremities

    Page :810-815

    Marc D Moncrieff, John F Thompson, Michael J Quinn, Jonathan R Stretch

    Résumé Résumé Plan Plan  
• • ·Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project

    Page :816-824

    Kenneth R Carson, Daniele Focosi, Eugene O Major, Mario Petrini, Elizabeth A Richey, Dennis P West, Charles L Bennett

    Résumé Résumé Plan Plan  
• • ·Genotype-guided tamoxifen therapy: time to pause for reflection?

    Page :825-833

    Timothy L Lash, Ernst A Lien, Henrik Toft Sørensen, Stephen Hamilton-Dutoit

    Résumé Résumé Plan Plan   
• • ·Mutations and cancer: one or two historical perspectives?

    Page :834

    Michael A Dyer, David H Abramson